[go: up one dir, main page]

BE852941A - Nouveaux derives de prostaglandine - Google Patents

Nouveaux derives de prostaglandine

Info

Publication number
BE852941A
BE852941A BE176164A BE176164A BE852941A BE 852941 A BE852941 A BE 852941A BE 176164 A BE176164 A BE 176164A BE 176164 A BE176164 A BE 176164A BE 852941 A BE852941 A BE 852941A
Authority
BE
Belgium
Prior art keywords
prostaglandin derivatives
new prostaglandin
new
derivatives
prostaglandin
Prior art date
Application number
BE176164A
Other languages
English (en)
Original Assignee
Labaz
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Labaz filed Critical Labaz
Publication of BE852941A publication Critical patent/BE852941A/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24Oxygen or sulfur atoms
    • C07D207/262-Pyrrolidones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C53/00Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen
    • C07C53/126Acids containing more than four carbon atoms
    • C07C53/128Acids containing more than four carbon atoms the carboxylic group being bound to a carbon atom bound to at least two other carbon atoms, e.g. neo-acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40Esters thereof
    • C07F9/4003Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4006Esters of acyclic acids which can have further substituents on alkyl

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrrole Compounds (AREA)
BE176164A 1976-03-31 1977-03-28 Nouveaux derives de prostaglandine BE852941A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL49325A IL49325A (en) 1976-03-31 1976-03-31 8-aza-11-deoxy-pge1 derivatives,their preparation and pharmaceutical compositions containing them

Publications (1)

Publication Number Publication Date
BE852941A true BE852941A (fr) 1977-09-28

Family

ID=11048789

Family Applications (1)

Application Number Title Priority Date Filing Date
BE176164A BE852941A (fr) 1976-03-31 1977-03-28 Nouveaux derives de prostaglandine

Country Status (18)

Country Link
US (1) US4115401A (fr)
JP (1) JPS52142060A (fr)
BE (1) BE852941A (fr)
CA (1) CA1074804A (fr)
CH (2) CH624101A5 (fr)
DD (1) DD130352A5 (fr)
DE (1) DE2714129A1 (fr)
ES (1) ES457385A1 (fr)
FR (1) FR2346332A1 (fr)
GB (1) GB1574246A (fr)
HU (1) HU178040B (fr)
IL (1) IL49325A (fr)
IT (1) IT1075373B (fr)
NL (1) NL7703503A (fr)
NO (1) NO149428C (fr)
PL (3) PL107544B1 (fr)
SE (1) SE417603B (fr)
SU (3) SU676162A3 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003074483A1 (fr) 2002-03-05 2003-09-12 Ono Pharmaceutical Co., Ltd. Composes derives de 8 azaprostaglandine et medicaments contenant ceux-ci comme principe actif

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE877595A (fr) * 1978-07-11 1980-01-10 Glaxo Group Ltd Nouveaux prostenoides et procede pour leur preparation
US4320136A (en) * 1980-08-11 1982-03-16 E. I. Du Pont De Nemours And Company 8-Aza-16,16-difluoroprostanoids
US4530933A (en) * 1982-12-27 1985-07-23 E. I. Du Pont De Nemours And Company 8-Aza-13-thiaprostanoids and a method of use thereof as anti-ulcer agents
US4456613A (en) * 1982-12-27 1984-06-26 E. I. Du Pont De Nemours And Company 6-Keto- and 6-hydroxy-8-azaprostanoids and anti-ulcer use thereof
TR200201643T2 (tr) 1999-12-22 2002-11-21 Pfizer Products Inc. Osteoporoz tedavisi için EP4 reseptörünü seçici agonistler.
JP3984164B2 (ja) * 2000-11-27 2007-10-03 ファイザー・プロダクツ・インク 骨粗鬆症治療用ep4受容体選択的アゴニスト
CA2451393C (fr) * 2001-07-16 2011-01-04 F. Hoffmann-La Roche Ag Derives de pyrrolidone comme antagonistes de prostanoide
ES2254726T3 (es) 2001-07-16 2006-06-16 F. Hoffmann-La Roche Ag Analogos de prostaglandina como agonistas receptores de ep4.
JP4273407B2 (ja) 2001-07-23 2009-06-03 小野薬品工業株式会社 Ep4アゴニストを有効成分とする骨量低下疾患の治療剤
JP2005526080A (ja) * 2002-03-18 2005-09-02 ファイザー・プロダクツ・インク 肝不全、動脈管閉鎖、緑内障又は高眼圧の治療のための選択的ep4受容体アゴニストの使用
KR100752891B1 (ko) * 2003-01-10 2007-08-28 에프. 호프만-라 로슈 아게 프로스타글란딘 작용제로서 2-피페리돈 유도체
US7179820B2 (en) 2003-06-06 2007-02-20 Allergan, Inc. Piperidinyl prostaglandin E analogs
US20080058375A1 (en) * 2004-01-08 2008-03-06 Elworthy Todd R 2-Piperidone derivatives as prostaglandin antagonists

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3975399A (en) * 1974-08-06 1976-08-17 E. I. Du Pont De Nemours And Company 1,5-Disubstituted-2-pyrrolidinones, -3-pyrrolin-2-ones, and -4-pyrrolin-2-ones

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003074483A1 (fr) 2002-03-05 2003-09-12 Ono Pharmaceutical Co., Ltd. Composes derives de 8 azaprostaglandine et medicaments contenant ceux-ci comme principe actif

Also Published As

Publication number Publication date
PL108289B1 (pl) 1980-03-31
IT1075373B (it) 1985-04-22
NO149428B (no) 1984-01-09
ES457385A1 (es) 1978-02-01
CH628032A5 (fr) 1982-02-15
SE417603B (sv) 1981-03-30
FR2346332B1 (fr) 1980-05-09
CA1074804A (fr) 1980-04-01
CH624101A5 (fr) 1981-07-15
NL7703503A (nl) 1977-10-04
SU715019A3 (ru) 1980-02-05
JPS52142060A (en) 1977-11-26
NO149428C (no) 1984-04-18
US4115401A (en) 1978-09-19
HU178040B (en) 1982-02-28
SU676162A3 (ru) 1979-07-25
DE2714129A1 (de) 1977-10-13
FR2346332A1 (fr) 1977-10-28
IL49325A0 (en) 1976-05-31
PL107544B1 (pl) 1980-02-29
GB1574246A (en) 1980-09-03
NO771134L (no) 1977-10-03
IL49325A (en) 1979-11-30
DD130352A5 (de) 1978-03-22
PL107643B1 (pl) 1980-02-29
PL197005A1 (pl) 1978-10-09
SU837321A3 (ru) 1981-06-07
SE7703698L (sv) 1977-10-01

Similar Documents

Publication Publication Date Title
BE851122A (fr) Nouveaux derives de prostaglandine
BE852060A (fr) Derives polyoxygenes du labdane
BE859912A (fr) Nouveaux derives de psoralene
BE860741A (fr) Derives du glucofurannose
BE852941A (fr) Nouveaux derives de prostaglandine
BE852141A (fr) Nouveaux derives de sulfonamide
NL7714172A (nl) Prostaglandinederivaten.
BE851846A (fr) Derives de 1-nitro-9-amonoacridine
BE850492A (fr) Nouveaux derives de la piperazine
FR2350340A1 (fr) Derives de thiouree
NL7607800A (nl) Prostaglandinederivaten.
BE851443A (fr) Nouveaux derives de la piperazine
BE859567A (fr) Derives piperidylideniques de benzo-xanthenes
BE859439A (fr) Nouveaux derives de piperazine
BE852457A (fr) Nouveaux derives 17-spirosultines
BE852813A (fr) Derives de la nicotinoylaminotriazine
NL7807292A (nl) Prostaglandinederivaten.
FR2322587A1 (fr) Derives du prostane
BE855851A (fr) Nouveaux derives de la nitroxoline
FR2351084A1 (fr) Nouveaux derives naphtyliques
BE857719A (fr) Derives de prostane
FR2313920A1 (fr) Derives du prostane
BE851503A (fr) Nouveaux derives de la 2-phenyl-2-hydroxyethylamine
FR2353291A1 (fr) Nouveaux derives du benzofuranne
FR2342963A1 (fr) Derives de la piperidine

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: SANOFI

Effective date: 19850328